ZA897005B - Pharmaceutical compositions for eliciting an immunostimulant effect - Google Patents

Pharmaceutical compositions for eliciting an immunostimulant effect

Info

Publication number
ZA897005B
ZA897005B ZA897005A ZA897005A ZA897005B ZA 897005 B ZA897005 B ZA 897005B ZA 897005 A ZA897005 A ZA 897005A ZA 897005 A ZA897005 A ZA 897005A ZA 897005 B ZA897005 B ZA 897005B
Authority
ZA
South Africa
Prior art keywords
eliciting
pharmaceutical compositions
immunostimulant effect
immunostimulant
effect
Prior art date
Application number
ZA897005A
Other languages
English (en)
Inventor
Jack Welling
Welling Jack
John Robert Stephenson
Robert Stephenson John
Original Assignee
Health Lab Service Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Lab Service Board filed Critical Health Lab Service Board
Publication of ZA897005B publication Critical patent/ZA897005B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA897005A 1988-09-15 1989-09-14 Pharmaceutical compositions for eliciting an immunostimulant effect ZA897005B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821656A GB8821656D0 (en) 1988-09-15 1988-09-15 Pharmaceutical compositions for eliciting immunostimulant effect

Publications (1)

Publication Number Publication Date
ZA897005B true ZA897005B (en) 1990-08-29

Family

ID=10643643

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897005A ZA897005B (en) 1988-09-15 1989-09-14 Pharmaceutical compositions for eliciting an immunostimulant effect

Country Status (8)

Country Link
EP (1) EP0434749B1 (xx)
JP (1) JP3072489B2 (xx)
AU (1) AU633851B2 (xx)
CA (1) CA1337113C (xx)
DE (1) DE68908414T2 (xx)
GB (1) GB8821656D0 (xx)
WO (1) WO1990002559A1 (xx)
ZA (1) ZA897005B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010058D0 (en) * 1990-05-04 1990-06-27 Health Lab Service Board Method and composition for the treatment of cancer
WO1993000109A1 (en) * 1991-06-28 1993-01-07 Genentech, Inc. Method of stimulating immune response using growth hormone
US5744139A (en) * 1991-06-28 1998-04-28 University Of Tennessee Research Corporation Insulin-like growth factor I (IGF-1) induced improvement of depressed T4/T8 ratios
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
JPH09509415A (ja) * 1994-02-14 1997-09-22 ジェンザイム・コーポレイション ワクチンアジュバントとしてのプロラクチン
CA2301000C (en) * 1997-08-28 2003-07-08 Cheil Jedang Corporation An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371462A (en) * 1982-01-21 1983-02-01 Genex Corporation Method for purification of anterior pituitary hormones
JPS60214798A (ja) * 1984-04-06 1985-10-28 Kyowa Hakko Kogyo Co Ltd 魚類の成長ホルモン
AU5598286A (en) * 1985-04-10 1986-10-16 Unisearch Limited Method of using human growth hormone to stimulate the growth of agricultural animals
AU604820B2 (en) * 1988-01-08 1991-01-03 Chaovanee Dr. Aroonsakul Method of treatment of central nervous system diseases such as alzheimer's disease and parkinson's disease and method of diagnosing alzheimer's disease

Also Published As

Publication number Publication date
JP3072489B2 (ja) 2000-07-31
JPH04500675A (ja) 1992-02-06
AU633851B2 (en) 1993-02-11
EP0434749B1 (en) 1993-08-11
WO1990002559A1 (en) 1990-03-22
GB8821656D0 (en) 1988-10-12
AU4324389A (en) 1990-04-02
DE68908414T2 (de) 1993-12-09
DE68908414D1 (de) 1993-09-16
EP0434749A1 (en) 1991-07-03
CA1337113C (en) 1995-09-26

Similar Documents

Publication Publication Date Title
GB2222772B (en) Pharmaceutical compositions
GB8822857D0 (en) Pharmaceutical formulations
GB2219940B (en) Pharmaceutical compositions
HU896876D0 (en) Pharmaceutical compositions
ZA897005B (en) Pharmaceutical compositions for eliciting an immunostimulant effect
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
GB8830406D0 (en) Pharmaceutical compositions
GB8804189D0 (en) Pharmaceutical compositions
GB8808117D0 (en) Pharmaceutical compositions
GB8822603D0 (en) Pharmaceutical compositions
GB8826289D0 (en) Pharmaceutical compositions
GB8829368D0 (en) Pharmaceutical compositions
GB8830169D0 (en) Pharmaceutical compositions
GB8830174D0 (en) Pharmaceutical compositions
GB8815443D0 (en) Pharmaceutical compositions
ZA897139B (en) Pharmaceutical compositions
ZA893224B (en) Pharmaceutical compositions
GB8814146D0 (en) Pharmaceutical compositions
GB8809840D0 (en) Pharmaceutical compositions
GB8809650D0 (en) Pharmaceutical compositions
GB8809225D0 (en) Pharmaceutical compositions
GB8808830D0 (en) Pharmaceutical compositions
GB8815444D0 (en) Pharmaceutical compositions
GB8801613D0 (en) Pharmaceutical compositions
IE882176L (en) Pharmaceutical compositions